NM_002749.4:c.34G>A

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS2_Supporting

The NM_002749.4(MAPK7):​c.34G>A​(p.Asp12Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00000418 in 1,436,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000042 ( 0 hom. )

Consequence

MAPK7
NM_002749.4 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.89

Publications

2 publications found
Variant links:
Genes affected
MAPK7 (HGNC:6880): (mitogen-activated protein kinase 7) The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is specifically activated by mitogen-activated protein kinase kinase 5 (MAP2K5/MEK5). It is involved in the downstream signaling processes of various receptor molecules including receptor type kinases, and G protein-coupled receptors. In response to extracelluar signals, this kinase translocates to cell nucleus, where it regulates gene expression by phosphorylating, and activating different transcription factors. Four alternatively spliced transcript variants of this gene encoding two distinct isoforms have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17367166).
BS2
High AC in GnomAdExome4 at 6 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAPK7NM_002749.4 linkc.34G>A p.Asp12Asn missense_variant Exon 2 of 7 ENST00000395604.8 NP_002740.2 Q13164-1A0A024QZ20

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAPK7ENST00000395604.8 linkc.34G>A p.Asp12Asn missense_variant Exon 2 of 7 1 NM_002749.4 ENSP00000378968.3 Q13164-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000484
AC:
1
AN:
206452
AF XY:
0.00000896
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000113
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000418
AC:
6
AN:
1436892
Hom.:
0
Cov.:
31
AF XY:
0.00000421
AC XY:
3
AN XY:
712644
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33024
American (AMR)
AF:
0.0000243
AC:
1
AN:
41146
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25554
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38592
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83118
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50976
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5740
European-Non Finnish (NFE)
AF:
0.00000455
AC:
5
AN:
1099316
Other (OTH)
AF:
0.00
AC:
0
AN:
59426
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000468
Hom.:
0
ExAC
AF:
0.00000827
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 14, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.34G>A (p.D12N) alteration is located in exon 2 (coding exon 1) of the MAPK7 gene. This alteration results from a G to A substitution at nucleotide position 34, causing the aspartic acid (D) at amino acid position 12 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.43
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
T;T;T;.;T;T
Eigen
Benign
-0.033
Eigen_PC
Benign
0.13
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.83
T;.;T;T;.;T
M_CAP
Uncertain
0.092
D
MetaRNN
Benign
0.17
T;T;T;T;T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
0.34
N;N;.;.;N;.
PhyloP100
3.9
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-0.58
N;N;.;N;N;.
REVEL
Benign
0.061
Sift
Uncertain
0.0030
D;D;.;T;D;.
Sift4G
Benign
0.56
T;T;T;T;T;T
Polyphen
0.28
B;B;.;.;B;.
Vest4
0.17
MutPred
0.24
Gain of catalytic residue at D12 (P = 0.185);Gain of catalytic residue at D12 (P = 0.185);Gain of catalytic residue at D12 (P = 0.185);Gain of catalytic residue at D12 (P = 0.185);Gain of catalytic residue at D12 (P = 0.185);Gain of catalytic residue at D12 (P = 0.185);
MVP
0.78
MPC
0.41
ClinPred
0.46
T
GERP RS
4.5
PromoterAI
0.0092
Neutral
Varity_R
0.12
gMVP
0.33
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs765309809; hg19: chr17-19282247; API